Gain insights into the results of the EPI-CARE and PEDISTAD atopic dermatitis studies – a short soundbite from EAACI 2022.
EPI-CARE and PEDISTAD are two studies assessing the prevalence and burden of atopic dermatitis. In this soundbite form EAACI 2022, Dr. Antonella Muraro, MD (Centro Allergie Alimentari, Italy), explores their methodologies and explains that type 2 inflammation is the predominant inflammatory pathway across atopic dermatitis subtypes.
Consultant Pediatric Allergist at the Department of Pediatrics of the University of Padova, Italy
See author’s profile